Regenxbio Inc.
RGNX
Revenue
89.01M
▲67.80M▲319.59%
3 Months ChangeAssets
490.93M
▲24.94M▲5.35%
3 Months ChangeLiabilities
216.73M
▲10.39M▲5.04%
3 Months ChangeFree Cash Flow
32.61M
▲88.62M▲158.21%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-17
Form 8-K
ID: 0000950170-24-107367
2024-08-06
Form 8-K
ID: 0001193125-24-194111
2024-08-01
Form 10-Q
ID: 0000950170-24-089320
2024-08-01
Form 8-K
ID: 0000950170-24-089278
2024-06-13
Form 8-K
ID: 0001193125-24-160146
2024-06-03
Form 8-K
ID: 0000950170-24-068050
2024-05-08
Form 10-Q
ID: 0000950170-24-055691
2024-05-08
Form 8-K
ID: 0000950170-24-055656
2024-03-11
Form 8-K
ID: 0001193125-24-064353
2024-02-27
Form 8-K
ID: 0000950170-24-021130